ViewsML’s AI-powered virtual immunohistochemistry (vIHC) platform replaces traditional wet-lab staining with a faster, cost-effective, and tissue-sparing digital workflow. Using only H&E-stained slides, our solution delivers accurate biomarker predictions and quantification in minutes—empowering researchers to make informed decisions without the need for additional tissue sectioning or staining.
Benefits include:
- Instantaneous results from routine H&E
- Up to 50% budget and 100% IHC time savings
- Multiple biomarkers from 1 H&E saving tissue
- High sensitivity and specificity (e.g., AUC of 0.902 for PR in breast cancer)